$Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib- based chemotherapy$

Treatment of refractory/relapsed adult acute lymphoblastic leukemia with bortezomib- based chemotherapy

Junmei Zhao,* Chao Wang,* Yongping Song, Yuzhang Liu, Baijun FangHenan Key Lab of Experimental Haematology, Henan Institute of Haematology, Henan Tumor Hospital, Zhengzhou University, Zhengzhou, People’s Republic of China  *These authors contributed equally to this work Abstract:...

Full description

Bibliographic Details
Main Authors:	Zhao J, Wang C, Song Y, Liu Y, Fang B
Format:	Article
Language:	English
Published:	Dove Medical Press 2015-06-01
Series:	International Journal of General Medicine
Online Access:	http://www.dovepress.com/treatment-of-refractoryrelapsed-adult-acute-lymphoblastic-leukemia-wit-peer-reviewed-article-IJGM

Similar Items

Treatment of Adult Patients with Relapsed/Refractory B-Cell Philadelphia-Negative Acute Lymphoblastic Leukemia
by: Enrico Maffini, et al.
Published: (2019-05-01)

Inotuzumab ozogamicin in the treatment of relapsed/refractory acute B cell lymphoblastic leukemia
by: Uy N, et al.
Published: (2018-04-01)

P501: ISATUXIMAB PLUS CHEMOTHERAPY FOR PEDIATRIC RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA OR ACUTE MYELOID LEUKEMIA (ISAKIDS): INTERIM EFFICACY ANALYSIS
by: André Baruchel, et al.
Published: (2023-08-01)

Inotuzumab ozogamicin is effective in relapsed/refractory extramedullary B acute lymphoblastic leukemia
by: Luca Bertamini, et al.
Published: (2018-11-01)

PB1736: CLINICAL ANALYSIS OF VENETOCLAX-BASED IN THE TREATMENT OF ADULT RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
by: Jing LI, et al.
Published: (2023-08-01)

Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children
by: Jiao Xie, et al.
Published: (2023-08-01)

Timed Sequential Salvage Chemotherapy for Relapsed or Refractory Acute Myeloid Leukemia
by: Bogdan Popescu, et al.
Published: (2019-12-01)

Effectiveness of chemotherapy using bortezomib combined with homoharringtonine and cytarabine in refractory or relapsed acute myeloid leukemia: a phase II, multicenter, prospective clinical trial
by: Chengtao Zhang, et al.
Published: (2023-08-01)

CAG regimen for refractory or relapsed adult T‐cell acute lymphoblastic leukemia: A retrospective, multicenter, cohort study
by: Jie‐Jing Qian, et al.
Published: (2020-08-01)

Impact of blinatumomab on patient outcomes in relapsed/refractory acute lymphoblastic leukemia: evidence to date
by: Hathaway L, et al.
Published: (2018-10-01)

Testicular relapse of acute lymphoblastic leukemia
by: Alexandra Carolan, et al.
Published: (2023-09-01)

Treatment for Relapsed/Refractory Acute Myeloid Leukemia
by: Felicitas Thol, et al.
Published: (2021-06-01)

Clinical Study of Venetoclax with Chemotherapy for Relapsed/Refractory Acute Myeloid Leukemia
by: CHEN Xiaofeng, WANG Meng, LI Zhongyu, LI Jiajia
Published: (2022-03-01)

Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia
by: Qingqing Zheng, et al.
Published: (2020-11-01)

Intraocular relapse of childhood acute lymphoblastic leukemia.
by: Somervaille, T, et al.
Published: (2002)

Novel Treatments for Pediatric Relapsed or Refractory Acute B-Cell Lineage Lymphoblastic Leukemia: Precision Medicine Era
by: Shang Mengxuan, et al.
Published: (2022-06-01)

Improvement of the Outcome of Relapsed or Refractory Acute Lymphoblastic Leukemia in Children Using a Risk-Based Treatment Strategy.
by: Francesco Ceppi, et al.
Published: (2016-01-01)

A phase 2 and pharmacological study of sapanisertib in patients with relapsed and/or refractory acute lymphoblastic leukemia
by: Aref Al‐Kali, et al.
Published: (2023-12-01)

CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
by: Vairy S, et al.
Published: (2018-11-01)

Treating relapsed or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia: liposome-encapsulated vincristine
by: Davis T, et al.
Published: (2013-09-01)

Venetoclax durable response in adult relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia with JAK/STAT pathway alterations
by: Anna Ferrari, et al.
Published: (2023-05-01)

P376: CD38: A FUNCTIONING TARGET IN RELAPSED/REFRACTORY ACUTE LYMPHOBLASTIC LEUKEMIA. LIMITATIONS IN TREATMENT AND DIAGNOSTICS.
by: B. Vakrmanova, et al.
Published: (2022-06-01)

P578: EFFECTIVENESS OF REINDUCTION CHEMOTHERAPY USING BORTEZOMIB WITH HOMOHARRINGTONINE AND CYTARABINE IN REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA: A PHASE II, MULTICENTER, PROSPECTIVE CLINICAL TRIAL
by: Chengtao Zhang, et al.
Published: (2023-08-01)

Corrigendum: Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia
by: Qingqing Zheng, et al.
Published: (2020-12-01)

Impact of Blinatumomab Treatment on Bone Marrow Function in Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
by: Hagop M. Kantarjian, et al.
Published: (2021-11-01)

Successful Treatment of Refractory and Relapsed CNS Acute Lymphoblastic Leukemia With CD-19 CAR-T Immunotherapy: A Case Report
by: Kyaw Thu Htun, et al.
Published: (2021-08-01)

Bortezomib (Velcade) in combination with dexamethasone eor relapsed or refractory myeloma
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

Evaluation of the combined effects of doxorubicin and bortezomib on the human acute lymphoblastic leukemia cell line
by: Korga Agnieszka, et al.
Published: (2019-06-01)

Inotuzumab ozogamicin and blinatumomab sequential therapy for relapsed/refractory Philadelphia chromosome-positive acute lymphoblastic leukemia
by: Tomoaki Ueda, et al.
Published: (2022-01-01)

Efficacy of combination of venetoclax with azacitidine or chemotherapy in refractory/relapse acute leukemias of ambiguous lineage, not otherwise specified
by: Kaiqi Liu, et al.
Published: (2021-09-01)

Efficacy of lenalidomide, bortezomib, and prednisolone in patients with relapsed or refractory multiple myeloma
by: T. A. Мitinа, et al.
Published: (2015-12-01)

FLAG with Bortezomib Salvage Therapy in Relapsed/Refractory Childhood Leukemia—A Reliable Bridge to Transplantation with Limited Toxicity
by: Sreedhar Jayakrishnan Cherulil, et al.

Optic nerve infiltration in relapse of acute lymphoblastic leukemia
by: Mohammad Javed Ali, et al.
Published: (2011-01-01)

Mutational profiling of acute lymphoblastic leukemia with testicular relapse
by: Ling-Wen Ding, et al.
Published: (2017-03-01)

Optic nerve infiltration in relapse of acute lymphoblastic leukemia
by: Mohammad Javed Ali, et al.
Published: (2011-01-01)

Acute lymphoblastic leukemia relapse presenting as retinal vasculitis
by: Imen Ksiaa, et al.
Published: (2020-08-01)

New-Onset Severe Cytopenia After CAR-T Cell Therapy: Analysis of 76 Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia
by: Linqin Wang, et al.
Published: (2021-06-01)

Improved outcome of children with relapsed/refractory acute myeloid leukemia by addition of cladribine to re‐induction chemotherapy
by: Min Ruan, et al.
Published: (2021-02-01)

Neurotoxicity Associated with Treatment of Acute Lymphoblastic Leukemia Chemotherapy and Immunotherapy
by: Patrycja Śliwa-Tytko, et al.
Published: (2022-05-01)

Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemia
by: Ibrahim Aldoss, et al.
Published: (2023-07-01)